Advertisement
 
YOU ARE HERE: LAT HomeCollectionsAmgen Inc

Amgen Chief Plans to Sell 100,000 Company Shares

VALLEY AND VENTURA COUNTY | VENTURA COUNTY ROUNDUP
/ BARBARA MURPHY

June 23, 1998|BARBARA MURPHY

Amgen Inc. Chairman Gordon M. Binder has filed papers to notify federal regulators of his plans to sell 100,000 shares of the company, almost 7% of the 1.5 million shares he owns, according to regulators.

The shares would be worth about $6.2 million.

Binder, chief executive of the world's largest biotechnology company, last sold Amgen stock in May, when he sold 84,000 shares. The Thousand Oaks company's share price rose to a 12-month high of $65.56 in late May on takeover speculation.

Business Week reported that Delaware-based DuPont Co. would make a $25-billion cash offer for the company. Both companies declined to comment.

The Thousand Oaks company sells two drugs whose annual sales exceed $1 billion--Epogen, for anemic dialysis patients, and Neupogen, which is used to treat a weakened immune system.

Advertisement
Los Angeles Times Articles
|
|
|